Home

Companies







aeChem

aeChem is dedicated to providing a range of platforms for modern personalized medicine. aeChem is based on a unique know-how, linking advanced organic chemistry and biology.

Avogen Tech

Avogen Tech is a start-up company whose mission is to develop a new generation of Electronic Cigarette.

Ceidos

Ceidos has developed a machine that automates the production of cell therapies, which are used in particular as a treatment for cancer.

CordSavings

Biobanque mixte et solidaire de cellules souches de cordon ombilical au service de la collectivité (conservation allogénique) ainsi que des familles (conservation autologue). CordSavings a...

ExcellGene

ExcellGene is involved in the production of recombinant proteins using mammalian cells, and in optimising the production processes concerned.

InflamAlps

Inflamalps est une entreprise basée au BioArk depuis 2012 et qui développe de nouvelles substances capables de combattre certaine maladies inflammatoires de l’œil et en particulier...

Karmagenes

Plateforme de test génétique pour déterminer les comportements, humeurs et caractères des personnes.

NVX Labs

NVX Labs is developing a new generation of thermal metered dose inhalers (tMDIs). These inhalers will open up new applications in the pharmaceutical and non-pharmaceutical markets.

REM Analytics

REM Analytics offers a complete development service. From proof of concept to production-ready prototype. They develop new microbiome-based therapies for various health conditions, including new customized...

Swissaustral Biotech SA

Swissaustral Biotech: Extreme Biotechnology Swissaustral Biotech SA is specialized on biotechnological applications of microorganisms from extreme environments, Extremophiles, and their bioactive compounds....

Vera Salus

Vera Salus Ricerca (VSR) is an innovative biotechnology discovery company whose core competencies are molecular engineering and recombination of natural compounds (from plants).

ViRelieve

ViRelieve is a development-stage biotechnology company focused on the development of novel antiviral therapies to treat infections using protein interference technology. 

Fondation The Ark - Rue de l'Industrie 23 - 1950 Sion - Suisse | Intranet The Ark